Medical device maker Teleflex to split into two
Teleflex said on Thursday it would split into two by spinning off its business that makes devices for the urology, and acute care markets as well as its contract manufacturing unit.
Insights Into Teleflex (TFX) Q4: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Teleflex (TFX) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Here's Why Teleflex (TFX) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Retain Teleflex Stock in Your Portfolio Right Now?
TFX stays on investors' radars due to its performance in the Vascular Access segment and expansion moves.
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?
Teleflex introduces the Arrowg+ard Blue Plus MSB Procedure Kit in the EMEA.
Why Teleflex (TFX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Teleflex (TFX) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Teleflex (TFX) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Teleflex (TFX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Teleflex (TFX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook
TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments.
Teleflex Incorporated (TFX) Q3 2024 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX ) Q3 2024 Results Conference Call October 31, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer Thomas Powell - Executive Vice President & Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC Matt Taylor - Jefferies Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Group David Turkaly - Citizens JMP Craig Bijou - Bank of America Michael Polark - Wolfe Research Mike Matson - Needham Kristen Stewart - CL King Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and will be available on the company's website for replay shortly.
